umbilical cord blood-derived MAK immune cells
Term · Oncology and biomedicine · MLC-T-ONC-017398
A preparation of mixed-activated killer (MAK) immune cells derived from human umbilical cord blood (UCB) cells, with potential cytotoxic activity. Hematopoietic stem cells (HSCs) are isolated followed by ex vivo differentiation and expansion. Upon administration, the UCB-derived MAK immune cells may lyse cancer cells.
| Identifier | MLC-T-ONC-017398 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | umbilical cord blood-derived mixed-activated killer immune cells; UCB-derived MAK immune cells; UCB-derived MAK cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017398",
"term": "umbilical cord blood-derived MAK immune cells",
"field": "Oncology and biomedicine",
"definition": "A preparation of mixed-activated killer (MAK) immune cells derived from human umbilical cord blood (UCB) cells, with potential cytotoxic activity. Hematopoietic stem cells (HSCs) are isolated followed by ex vivo differentiation and expansion. Upon administration, the UCB-derived MAK immune cells may lyse cancer cells.",
"synonyms": [
"umbilical cord blood-derived mixed-activated killer immune cells",
"UCB-derived MAK immune cells",
"UCB-derived MAK cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/umbilical-cord-blood-derived-mak-immune-cells/"
}
Record 16,925 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.